The C. elegans LON-1 protein requires its CAP domain for function in regulating body size and BMP signaling
- PMID: 39657262
- PMCID: PMC11796460
- DOI: 10.1093/genetics/iyae202
The C. elegans LON-1 protein requires its CAP domain for function in regulating body size and BMP signaling
Abstract
The CAP (cysteine-rich secretory proteins, antigen-5, and pathogenesis-related) proteins are widely expressed and have been implicated to play diverse roles ranging from mammalian reproduction to plant immune response. Increasing evidence supports a role of CAP proteins in lipid binding. The Caenorhabditis elegans CAP protein LON-1 is known to regulate body size and bone morphogenetic protein (BMP) signaling. LON-1 is a secreted protein with a conserved CAP domain and a C-terminal unstructured domain with no homology to other proteins. In this study, we report that the C-terminal domain of LON-1 is dispensable for its function. Instead, key conserved residues located in the CAP domain are critical for LON-1 function in vivo. We further showed that LON-1 is capable of binding sterol, but not fatty acid, in vitro, and that certain key residues implicated in LON-1 function in vivo are also important for LON-1 sterol binding in vitro. These findings suggest a role of LON-1 in regulating body size and BMP signaling via sterol binding.
Keywords: C. elegans; BMP signaling; CAP; LON-1; body size; fatty acid binding; sterol binding.
© The Author(s) 2024. Published by Oxford University Press on behalf of The Genetics Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
Conflicts of interest: The author(s) declare no conflict of interest.
References
-
- Ali SA, Steinkasserer A. 1995. PCR-ligation-PCR mutagenesis: a protocol for creating gene fusions and mutations. Biotechniques. 18:746–750. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous